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Abstract
Background: The international evidence about outcomes of End Stage Kidney Disease (ESKD) for ethnic minorities
was reviewed to identify gaps and make recommendations for researchers and policy makers.
Methods: Nine databases were searched systematically with 112 studies from 14 different countries included and
analysed to produce a thematic map of the literature.
Results: Reviews (n = 26) highlighted different mortality rates and specific causes between ethnic groups and by
stage of kidney disease associated with individual, genetic, social and environmental factors. Primary studies
focussing on uptake of treatment modalities (n = 19) found ethnic differences in access. Research evaluating
intermediate outcomes and quality of care in different treatment phases (n = 35) e.g. dialysis adequacy, transplant
evaluation and immunosuppression showed ethnic minorities were disadvantaged. This is despite a survival
paradox for some ethnic minorities on dialysis seen in studies of longer term outcomes (n = 29) e.g. in survival time
post-transplant and mortality. There were few studies which focussed on end of life care (n = 3) and ethnicity.
Gaps identified were: limited evidence from all stages of the ESKD pathway, particularly end of life care; a lack of
system oriented studies with a reliance on national routine datasets which are limited in scope; a dearth of
qualitative studies; and a lack studies from many countries with limited cross country comparison and learning.
Conclusions: Differences between ethnic groups occur at various points and in a variety of outcomes throughout
the kidney care system. The combination of individual factors and system related variables affect ethnic groups
differently indicating a need for culturally intelligent policy informed by research to prevent disadvantage.
Keywords: Inequalities, Ethnic minorities, Kidney disease, Scoping, Review
Background
Inequalities in some aspects of End Stage Kidney Disease
(ESKD) in the United Kingdom (UK) had been well docu-
mented prior to this study. However, to ensure that future
research would be based on the most comprehensive evi-
dence this scoping review was commissioned by a national
kidney charity in 2017, the topic having been identified
through prioritisation process involving people affected by
kidney disease as well as clinicians and researchers. This
review was the first step in a systematic approach to learn
as much as possible from the evidence about inequalities
in outcomes for people living and dying with ESKD who
are from ethnic minority groups. This paper describes the
approach (protocol) used, presents a map of the literature
and highlights where there are gaps to be addressed
through future research and policy.
Investigating inequalities in kidney care and how they
impact upon ethnic minorities is not only necessary for
reducing inequalities in the UK but is also likely to bene-
fit the understanding of access to care for other groups
with ESKD globally as well. This review therefore took a
broad perspective and incorporated the international lit-
erature. The objectives of this international systematic
scoping review were to:
 identify the evidence base of inequalities in the
outcomes of end stage kidney disease for ethnic
minorities;
 map the international literature;
 identify gaps and make recommendations for
research and policy towards reducing and
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preventing inequalities in kidney care in the UK and
globally.
Methods
This systematic scoping review was conducted in line
with the 5 stage framework outlined by Arksey and
O’Malley [1]: protocol and search question development;
systematic searching and record management; sifting
and refining; charting and mapping. The research ques-
tion was initially determined via a Delphi study and then
refined via discussion within the project team to “Why
do ethnic minority patients with End Stage Kidney
Failure (ESKD) experience poorer outcomes than non-
ethnic minority patients?”.
A systematic scoping review is an early and essential
step towards answering the ‘why’ question but necessar-
ily falls short of doing so as it does not apply or build
theory for this. It provides a map of the literature, high-
lights the issues that other researchers have addressed
and shows where there are gaps. It follows a systematic
protocol as described in this Methods section and offers
up observations and recommendations for next steps
which are listed in the Conclusion.
The search strategy and literature searches were
formulated and refined by EW and AB to be compre-
hensive and include sources from health, sociology and
psychology which considered minority health and any
aspect of end stage kidney disease (dialysis, renal re-
placement therapy, transplant or conservative care and
end of life care) in comparison to non-ethnic minorities
and in relation to the following outcomes:
 Morbidity, mortality, kidney related, service related,
transplant related
 Measures of mental health (e.g. reduction in anxiety
or depression using validated tools)
 Measures of emotional well-being or quality of life:
(using validated tools).
The definition of ethnic minority was taken from Cul-
ley [2] and ethnicity defined as ‘a consciousness of
belonging to a particular group based on commonality
of family origin and culture of shared values and beliefs
which is socially constructed’.
A time frame of 1992 onwards was set to capture
evidence from the last 25 years. The searches were wide
and sensitive and encompassed a range of thesaurus and
free text terms to describe the different descriptors of
ethnic minorities and the capture the terms related to
end stage kidney failure or disease. Table 1 provides an
example of one search strategy for one database.
9 electronic databases were searched to identify
studies for inclusion in the review (see Table 2
below). There was insufficient resource within the
project to search journals and grey literature that
could have expanded the potential range of studies
to be included.
The searches were undertaken by EW and AB in Au-
gust 2017 and all records were uploaded on to the End-
note database. Using the inclusion and exclusion criteria
shown in Table 3, each record was screened independ-
ently on the basis of title by the researcher (EW). A 10%
sample of titles were screened by a different member of
the research team, any discrepancies resolved, and then
the studies were screened by abstract and full text by
EW and either included or excluded according to the
criteria.
Figure 1 illustrates the searching and sifting process
for this review. Data was extracted into a series of evi-
dence tables by EW and MW following project team dis-
cussions regarding the column headings and data to be
extracted. This included details on author, publication
year, author country, ethnic group(s) in focus, research
type, research objective, outcomes / indicators and brief
summary of findings.
The data was analysed thematically and a map of the
data produced to aid analysis, see Fig. 3.
Results
112 studies were included in this review. These focussed
on ESKD and included analysis of outcomes for ethnic
minorities in 14 different countries listed in Fig. 2 which
shows a breakdown of the included papers by author
country of origin and / or country focus. The majority of
included studies concerned the US (n = 72) followed by
the UK (n = 15), Australia (n = 9), Canada (n = 4) and the
Netherlands and New Zealand (n = 3) with the other
eight countries (Singapore, Brazil, Mexico, Romania,
Israel, France, Hungary and India) being the focus of
only one or two studies each.
Included studies related to five different areas or themes
which were identified as: an overview of the question topic
area in the form of a review (Theme 1); access to a modal-
ity of RRT care i.e. access to haemodialysis, peritoneal dia-
lysis, conservative care (Theme 2); care on dialysis and /
or being listed for a transplant and moving through the
transplant process with a focus on intermediate outcomes
(Theme 3); longer term outcomes and survival (Theme 4)
and end of life care (Theme 5).
Theme 1 reviews of the topic area
Twenty-six included studies were reviews, none of which
systematic, and they ranged in scope and detail subdivid-
ing into five subsets: those with a focus on CKD, hyper-
tensive kidney disease, a general focus, dialysis and
transplantation.
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Reviews with a focus on CKD [3–7]
As survival and risk change over time and according to
stage and treatment, these studies suggested that inter-
ventions should be stratified and tailored in a similar
way with prospective longitudinal and cohort research
needed which include ethnic minority groups. Further-
more, the multiplicity of factors which put different eth-
nic minorities at increased risk of CKD and ESKD
(hypertension, Type 2 Diabetes Mellitus (T2DM), albu-
minuria) call for a complex analysis of system-related as
well as physiological factors through more cross popula-
tion multi-levels studies. The urgency of prevention in
countries where there are geographical and economic
constraints on access to dialysis but increasing incidence
in ESKD amongst particular indigenous groups,
highlighted the ethical and moral necessities of interven-
tion from a global perspective.
Review with a focus on hypertensive kidney disease [8]
This paper illustrated the different patterns in ESKD
among different ethnic groups within diverse popula-
tions which vary from country to country and how eth-
nicity relates to hypertensive kidney disease as the
predominant cause of ESKD for African Americans. The
range of mediators which can impact on hypertensive
ESKD e.g.: socio-demographics; access to healthcare;
Table 1 Example of one search strategy (Medline database)
1. exp. Kidney Failure, Chronic/
2. exp. Renal Replacement Therapy/
3. kidney/
4. exp. kidney diseases/
5. exp. renal insufficiency/
6. exp. renal dialysis/
7. Glomerular Filtration Rate/
8. transplantation.mp. [mp = title, abstract, original title, name of
substance word, subject heading word, keyword heading word,
protocol supplementary concept word, rare disease supplementary
concept word, unique identifier, synonyms]
9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8
10. Treatment Outcome/ or “Outcome Assessment (Health Care)”/ or
outcome assessment.mp. or “Outcome and Process Assessment (Health
Care)”/
11. outcome measure*.mp. [mp = title, abstract, original title, name of
substance word, subject heading word, keyword heading word,
protocol supplementary concept word, rare disease supplementary
concept word, unique identifier, synonyms]
12. exp. Health Status/
13. exp. “Quality of Life”/
14. health impact assessment/
15. well-being.mp.
16. exp. Mental Disorders/
17. exp. Depression/
18. Anxiety/
19. Stress, Psychological/
20. exp. Dementia/
21. exp. Cardiovascular Diseases/
22. end of life care.mp. or Terminal Care/
23. palliative care.mp. [mp = title, abstract, original title, name of
substance word, subject heading word, keyword heading word,
protocol supplementary concept word, rare disease supplementary
concept word, unique identifier, synonyms]
24. conservative care.mp. [mp = title, abstract, original title, name of
substance word, subject heading word, keyword heading word,
protocol supplementary concept word, rare disease supplementary
concept word, unique identifier, synonyms]
25. mortality.mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
26. morbidity.mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
27. survival.mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
28. 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21
or 22 or 23 or 24 or 25 or 26 or 27
29. exp. Ethnic Groups/
30. exp. Continental Population Groups/
31. exp. Minority Health/
32. bme.mp.
33. bame.mp.
34. racial.mp.
35. cald.mp. [mp = title, abstract, original title, name of substance word,
subject heading word, keyword heading word, protocol supplementary
concept word, rare disease supplementary concept word, unique
identifier, synonyms]
36. south asian.mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
37. indo asian.mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
Table 1 Example of one search strategy (Medline database)
(Continued)
38. indian.mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
39. caucasian.mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
40. exp. African Americans/
41. exp. Hispanic/
42. exp. White/
43. exp. Black/
44. indigenous.mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
45. inequality.mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
46. exp. Health Status Disparities/ or exp. Prejudice/ or exp. Ethnic
Groups/ or intersectionality.mp. or exp. “Emigration and Immigration”/
or exp. Social Class/
47. 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40
or 41 or 42 or 43 or 44 or 45 or 46
48. exp. research design/
49. exp. empirical research/
50. exp. qualitative research/
51. 48 or 49 or 50
52. 9 and 28 and 47 and 51
53. limit 52 to yr. = “1992 -Current”
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blood pressure management; and differences in
outcomes on renal replacement therapy (RRT) were
described. The earlier onset and more severe disease
could be partly explained by worse access to healthcare
associated with lower socioeconomic status.
Reviews with a general focus [9–11]
These studies provide some general observations on
inequalities in relation to a variety of different ethnic
groups and African and Native Americans. There is
more rapid progression from CKD to ESKD in ethnic
minorities; minority groups have worse access to care
and late referral to specialist renal care. Although
transplantation is the ‘best’ treatment for many
people, wait time to transplantation is longer for eth-
nic minorities due to delays in completing the trans-
plant evaluation process and because of lack of
suitable matched organs. These three reviews draw at-
tention to the need for culturally competent preven-
tion at the same time as continuing with research to
investigate why there are different outcomes seen in
ethnic minority groups. The influence of socio-
economic factors such as education, social status and
associated attitudes towards treatment options for
ESKD, and quality of life on RRT compared to major-
ity population groups, are aspects which require bet-
ter understanding.
Reviews with a focus on dialysis [12–16]
Five reviews focussed on ESKD from the perspective
of dialysis services in the UK, Europe, the US and
other parts of the world e.g. Israel. The overarching
premise was that the incidence of ESKD and associ-
ated need for dialysis is steadily increasing with differ-
ences between ethnic groups and associated with
changing age structure of populations. These reviews
with a focus on different aspects of dialysis care came
with the caveat that long term survival of ESKD is
very low and survival advantages on dialysis are mar-
ginal compared to transplantation with a living donor
graft which can extend life considerably but still not
back to normal lifespan. Although a survival advan-
tage has been seen in some ethnic groups on dialysis
a need for a better understanding of the underlying
mechanisms behind the differences and taking action
on barriers to access both in the pathway to ESKD
but also in access to care on dialysis including trans-
plantation was highlighted.
Table 3 Inclusion and Exclusion Criteria
Inclusion Exclusion
● Studies (including systematic reviews and all study designs) that mention
ethnic minority health in line with the above definition and in relation to end
stage kidney disease and related descriptions (end stage renal failure, dialysis,
end of life kidney care).
● Evidence of a measurable outcome on health or wellbeing (e.g. physical or
mental health or physiological or quality of life or wellbeing)
● Studies which concern any of the related end stage kidney disease descriptors:
○ Patients on any kind of dialysis
○ Patients on Renal replacement therapy
○ Transplant patients
○ End stage renal failure
● Adults over 18
● Studies in English, post 1992
● Any country
● A comparison with non-ethnic minority group (s)
● Studies outside the agreed definition of ethnic minority
● Studies with no measurable outcomes that relate to health
● Studies which do not concern any of the related end stage
kidney failure descriptors:
○ Patients on any kind of dialysis
○ Transplant patients
○ End stage renal failure
● Children less than 18
● Studies in languages other than English, prior to 1992
● Studies that do not have a comparison with non-ethnic
minority group (s)
● Studies that are commentaries, editorials (which do not
present data), thought pieces or conference abstracts
Table 2 Databases searched and number of references retrieved
Database name Focus Number of references retrieved
Medline Biomedical 185
Cinahl Nursing and allied health 534
Psychinfo Psychology/Mental Health 78
Web of Science/Web of Knowledge Science/Social Sciences 224
Scopus General 577
Social Care Online Social Care 53
ASSIA Social Science 370
Global Health Health 97
Cochrane Database of Promoting Health Effectiveness Reviews Systematic Reviews 17
Total 9 databases 2135
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Fig. 2 Breakdown of included articles by country of author origin and / or focus
Fig. 1 Searching and sifting process
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Reviews with a focus on transplantation [17–28]
Twelve reviews concerned inequalities in the trans-
plantation process or transplantation outcomes. The
overarching premise being that ethnic minorities, al-
though disproportionately represented in patient
populations with ESKD, receive fewer transplants
and wait longer to receive a transplant. These re-
views gave perspectives that varied according to the
level of focus: global; country; population; individual
as well as stage in the transplant process (pre-emp-
tive transplantation, referral to waiting list, organ al-
location, graft survival and immunosuppression) and
donation. Overarching conclusions were that better
understanding and communication would lead to in-
creased awareness of how the social and individual
risk factors interact through the system which is ne-
cessary for improving access and reducing
inequalities.
Theme 2 disparities in access & treatment modalities
Nineteen studies reported access to kidney care treat-
ment modalities - dialysis, transplant and conservative
care, post diagnosis of ESKD.
Sixteen out of the 19 were cohort designs, 1 observa-
tional – cross sectional, 1 mixed method and ethno-
graphic, 1 other (review of registry report data). The
studies spanned 6 countries.
Indicators related to access to RRT modalities were:
incidence or prevalence on the modality; rate of accept-
ance; planned and unplanned initiation; time to modal-
ity; waiting list probability; time from acceptance onto
waiting list to transplantation (and rate); time from start
of RRT to transplantation (and rate); transplantation
rate.
Access to dialysis – peritoneal dialysis and hemodialysis
[29–37]
Studies described differences in uptake of dialysis mo-
dality by different ethnic minority groups compared
to majority populations. These were not consistent
between different countries and different minority
populations highlighting that despite commonalities
ethnic minorities are diverse groups whose experi-
ences vary from country to country and on an indi-
vidual level.
The sociocultural context of renal replacement therapy
featured as an important consideration with a focus on
possible explanatory factors for the larger prevalent eth-
nic minority population on dialysis compared to the
general population. A third of the countries represented
in this review had a national kidney data service which
contributed to the research picture by providing quanti-
tative analysis of some elements.
Access to transplantation [38–47]
Studies showed that ethnic minorities with ESKD are
disproportionately represented in the transplantation
modality and identified a range of reasons that relate to
the different countries’ transplant systems. These
included the rates of being listed for transplant; move-
ment from list to transplantation; variations across
transplant centres as well in pre-dialysis care and cadav-
eric and life donation rates, which all showed disparities
when ethnic minorities were compared with majority
populations. The requirement for future research and
service development to take stratified and systemic ap-
proaches towards improving access to transplantation to
redress these inequalities was raised - as despite being
highly technical, dialysis and transplantation are part of
a complex process which is influenced by human and
sociological factors.
Theme 3 disparities in quality of care and intermediate
outcomes
Thirty-five studies investigated ethnic differences in
intermediate outcomes of treatment for ESKD.
Sixteen out of the 35 were cohort designs, 12 other
observational (cross sectional, survey, discrete choice ex-
periment); 3 other (programme review, record review,
simulation), 3 qualitative and 1 randomised controlled
trial (RCT). The studies spanned 6 countries.
Intermediate outcomes related to kidney function
were: estimated glomerular filtration rate (eGFR); pro-
teinuria / serum albumin; indicators of quality of care
e.g. dialysis dose / dialysis adequacy expressed as Kt/V,
urea reduction ratio (URR), anaemia and mineral man-
agement, infections, hospitalisation, communication &
information; indicators of health and wellbeing or behav-
iour i.e. nutritional status, quality of life (QOL), coping
style; indicators for movement through clinical pathways
i.e. through the transplant evaluation and allocation
process; transplant indicators e.g. antibody matching,
immunosuppression; and indicators of organisational or
system function e.g. issues of insurance, allocation prior-
ities, centre level variations, system level intervention.
Ethnic minorities are younger at referral to specialist
kidney care and as they often face a longer wait for a
transplant so that time spent on dialysis or moving
through the transplant process is both an opportunity
and a risk for outcomes later in the pathway. The choice
of dialysis modality and type of vascular access can be
associated with ESKD outcomes and researchers investi-
gated these for disparities amongst ethnic groups.
Quality of care - dialysis [48–63]
Studies reported on indicators of dialysis care such as
hemodialytic dose as well as clinical outcomes such as
time to first infection episode and found there these
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varied by different ethnic groups and required further
explanation. Other indicators of maintaining health
whilst on dialysis and associated outcomes such as qual-
ity of life similarly suggested a stratified approach to
identifying related inequalities was necessary as there are
age, gender and ethnicity associations to be understood.
Links back to wider system variables again were made.
Quality of care– transition to transplant [64–75]
Ethnic disparities in the transition from diagnosis of
ESKD or dialysis to transplant were investigated in 10 of
the included studies. The low transplant rates for ethnic
minorities which are seen overall in many countries can
be linked to disparities further back in the pathway well
as availability of suitable donor organs. Barriers respon-
sible for differences in completion of stages and move-
ment through the transplant process were associated
with minority ethnicity and linked to levels of informa-
tion given, knowledge and communication between pa-
tient and physician but also within wider networks.
Quality of care – the system [76–82]
Disparities in the transplant process were associated
with ethnicity for some groups and related to interaction
with kidney allocation and transplantation systems and
influenced by a wide range of factors such as geography,
clinician–patient communication, insurance and vari-
ation across centres in the same system. These studies
highlighted the complexity of transplantation systems.
Theme 4 disparities in longer term outcomes
Twenty-nine studies focussed on patient survival out-
comes for dialysis and transplantation.
Twenty-five out of the 29 were cohort designs and 4
were other observational studies. Collectively they inves-
tigated differences in outcomes across 12 broad ethnic
groups, 3 analysing by ethnic subgroups. The studies
spanned 8 countries.
Longer term outcomes relating to dialysis and trans-
plantation were: survival time on dialysis; time post-
transplant; hospitalisation, infection; allograft rejection;
quality of life (QOL); and mortality.
The outcomes for dialysis and transplantation varied
across different ethnicities, subgroups and stratification
by other variables: age, comorbidities (type 1 diabetes
mellitus (T1DM), type 2 diabetes mellitus (T2DM),
Lupus Nephritis) and location.
Overarching outcomes of ESKD [83–87]
Studies that reported the overarching outcomes of ESKD
identified inequalities faced by particular populations
and subgroups drawing attention to the disproportionate
burden of dialysis and mortality attributed to rates and
risk of diabetes and kidney complications. Other studies
highlighted how ethnic inequalities in outcomes can be
linked to area differences within countries and across
regions.
Dialysis outcomes [88–101]
Some ethnic minorities have been found to have longer
survival on dialysis than the majority population and this
apparent survival paradox is against the background of
increased risk, faster progression to ESKD and poorer
survival in the general population overall. The dialysis
survival advantage was not seen to be consistent across
the groups studied with different ethnicities and comor-
bidities; cultural and genetic differences as well as vari-
ation in access and delivery of care accounting for this.
Transplantation outcomes [102–111]
The reduced likelihood of having a transplant is a dis-
parity many ethnic minority patients face and studies in-
vestigated risks as well as survival outcomes. Ethnic
group and comorbidities were found to be associated
with this with greater disparities seen when live and de-
ceased donation were compared. To understand the im-
pact of ethnicity on transplant survival outcomes
research investigated other risks underpinning delayed
graft function, acute rejection episodes, expanded-
criteria donor, impaired graft function which for some
ethnicities was an independent risk. Differential rates of
risks and survival between ethnic groups were found in
some studies.
Theme 5 disparities in end of life care [112–114]
Three studies that focussed on disparities in end of life
care for people with ESKD were included in this review.
These studies all came from one country, the US. Two
had RCT designs and 1 was a cohort study.
Ethnic minorities were less likely to withdraw from
dialysis before death than the majority population with
differences explained by sociocultural rather than med-
ical factors. Research in this area included two studies
which attempted to understand and improve end of life
care for all kidney patients through culturally sensitive
intervention.
Discussion
ESKD is a multifaceted condition with many clinical and
sociological elements and there are multiple stages and
timings to consider in achieving the best outcome for
individuals living with the condition. Within the re-
search literature individuals are generally aggregated into
groups to look for evidence of inequalities and this
international scoping review has identified that there are
disparities between ethnic and non-ethnic minority
populations in all aspects of ESKD progression and
management.
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The search strategy for this review was formulated and
conducted by an experienced health researcher (EW) and
an expert in literature searching and systematic reviewing
(AB). It was designed to be as wide as possible within the
resource and time constraints for the work. Tests for pub-
lication bias were not conducted nor were reference lists
mined or grey literature searched, and these are limita-
tions. However, the research question and search strategy
were kept intentionally broad, reviews were included, and
the search resulted in studies that used a range of different
outcome indicators which related to the different clinical
and social elements and stages of care for ESKD. The
variety of studies and their juxtaposition within the ESKD
field enabled a useful overview of the evidence base,
notwithstanding any publication bias.
Figure 3 is a visual representation of the main themes
in relation to each other and served to highlight some of
the gaps. The different themes corresponded to specific
elements of the kidney care system – access to treatment
modalities, dialysis, transplantation and end of life care
– and this review is the first, as far as we are aware, to
map the evidence of inequalities in the ESKD field as a
whole. This review therefore is a comprehensive starting
point for researchers and policy makers to consider
where and in what form evidence exists on inequalities
in ESKD for ethnic minorities.
Although this review mapped the literature across a
schematic ESKD pathway, it highlighted an absence of
longitudinal cohort studies (retrospective or prospective)
which followed CKD patients as they progress through
that pathway. There was also a dearth of studies in two
particular areas of ESKD: system-related outcomes and
end of life care. The lack of longitudinal and system-
related studies may be due to the difficulties of conduct-
ing complex systems-related research whereas the lack
of end of life studies could reflect a lack of recognition
of end of life care as distinct element of kidney care, as
well as difficulties in defining end of life and barriers to
conducting research in that context.
The literature was also predominantly quantitative and
so was limited in helping understand the basis of the dif-
ferences in outcomes between ethnic groups. Although
national registries were a valuable source of data, espe-
cially regarding records and analyses of outcomes by
ethnic group [13], the national routine datasets do not
include indicators for all elements of care, nor analysis
at an individual level. Cultural aspects of ethnicity such
as attitudes towards death and dying come into play at
end of life and there are cultural differences between dif-
ferent parts of healthcare systems so that more qualita-
tive research would help understanding of the individual,
cultural and social factors which influence the disparities
in outcomes in these and other areas of ESKD. Further-
more, more qualitative and mixed method studies would
help to build theories about why inequalities exist and
how they can be addressed going forward.
Fig. 3 A map of the international literature on comparative studies of minority ethnicity and ESKD
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The majority of the evidence for this review has
come from a small number of countries and regions
notably the US, UK and Australasia. Reasons for the
lack of research in other countries, particularly in
lower income settings, may reflect how kidney care is
funded and delivered in individual countries; the ab-
sence of national data sets concerning ESKD; or the
lack of ethnicity data. This review highlights the com-
plexities of the kidney and transplant care systems
which people with ESKD engage with. Systems in dif-
ferent countries may share some common features
but they may also be country specific so that more
research and analyses of inequalities in ESKD globally,
with cross country comparisons, and a systems ap-
proach, would help to share learning and build on
this evidence.
Individual countries like the UK, where there is
the National Health Service and a national kidney
data registry, can not afford to rest on their laurels
because as Feehally [9], Lightstone [12] and Rand-
hawa [27] have been suggesting over the past 20
years, the UK’s changing demography towards
greater ethnic diversity together with a donation
shortage, means that without concerted evidence-
based intervention ethnic minorities will continue to
experience inequalities in outcomes for ESKD. Fur-
thermore, as ethnic minorities are highly heteroge-
neous groups, culturally intelligent approaches are
needed to understand the barriers and enablers of
access within individual country systems and to learn
from international comparisons.
Conclusions – gaps in the evidence
Differences between ethnic groups occur at various
points and in a variety of outcomes throughout the
ESKD care system. The combination of individual fac-
tors and system related variables affect ethnic groups
differently indicating a need for culturally intelligent pol-
icy informed by research to prevent disadvantage.
This thematic analysis contributes to the international
research evidence by mapping the different elements of
ESKD research where inequalities for ethnic minorities
have been observed. A number of gaps in the inter-
national literature have been highlighted which if ad-
dressed would strengthen our understanding of why
inequalities exist for people from ethnic minority groups
who are living and dying with ESKD.
Gap 1
There is a lack of evidence at all stages in the ESKD
pathway and a lack of longitudinal cohort studies (retro-
spective or prospective) which follow CKD patients as
they progress through the pathway.
Gap 2
The lack of system oriented research into ESKD and a
reliance on primary studies using national routine data
limits our understanding of how the different elements
in the system work together.
Gap 3
There is a lack of qualitative studies contributing to the
evidence base and the literature is predominantly quan-
titative. This limits a full understanding of the factors
that influence disparities in ESKD outcomes.
Gap 4
There is a lack of evidence from many countries apart
from the US, especially low-resource settings, and this
limits the possible learning across and between
countries.
Abbreviations
CKD: Chronic kidney disease; eGFR: Estimated glomerular filtration rate;
ESKD: End stage kidney disease; Kt/V: Dialysis adequacy (K = dialyser
clearance of urea, t = dialysis time, V = volume of distribution of urea);
QOL: Quality of Life; RCT: Randomised controlled trial; RRT: Renal
replacement therapy; T1DM: Type 1 diabetes mellitus; T2DM: Type 2 diabetes
mellitus; URR: Urea reduction ratio
Acknowledgements
Not applicable.
Authors’ contributions
EW and AB formulated and conducted the search strategies. EW and MW
extracted data into charting tables. EW conducted the analysis with
oversight and advice from AB and GR. EW drafted this paper and all authors
read and approved the final manuscript.
Funding
This study was supported with funding from Kidney Research UK and the
research topic was initiated following a prioritisation process which the
charity funded.
Availability of data and materials
Not applicable as this was a review of existing published literature.
Ethics approval and consent to participate
Not applicable as this was a review of existing published literature.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1Institute for Health Research, University of Bedfordshire, Luton, Bedfordshire,
UK. 2School of Health and Society, University of Salford, Manchester, UK.
Received: 14 November 2018 Accepted: 6 June 2019
References
1. Arksey H, O’Malley L. Scoping studies: towards a methodological framework.
Int J Soc Res Methodol. 2005;8(1):19–32.
2. L C. Nursing, culture and competence. In: Ethnicity and Nursing Practice, C.
L.a.D. S. Basingstoke: Palgrave; 2001. p. 109–27.
Wilkinson et al. BMC Nephrology          (2019) 20:234 Page 9 of 12
3. Alves TP, Lewis J. Racial differences in chronic kidney disease (CKD) and
end-stage renal disease (ESRD) in the United States: a social and economic
dilemma. Clin Nephrol. 2010;74(SUPPL.1):S72–7.
4. Nicholas SB, Kalantar-Zadeh K, Norris KC. Racial disparities in kidney disease
outcomes. Semin Nephrol. 2013;33(5):409–15.
5. Norris KC, Agodoa LY. Unraveling the racial disparities associated with
kidney disease. Kidney Int. 2005;68(3):914–24.
6. Patzer RE, McClellan WM. Influence of race, ethnicity and socioeconomic
status on kidney disease. Nat Rev Nephrol. 2012;8(9):533–41.
7. Weil EJ, Nelson RG. Kidney disease among the indigenous peoples of
Oceania. Ethnicity & disease. 2006;16(2 Suppl 2):S2–24-30.
8. Agodoa L. Hypertensive kidney disease in African Americans. Nephrology.
2001;6(1):25–31.
9. Feehally J. Ethnicity and renal replacement therapy. Blood Purif. 2010;29(2):125–9.
10. Gadegbeku C, Freeman M, Agodoa L. Racial disparities in renal replacement
therapy. J Natl Med Assoc. 2002;94(8):45S–54S.
11. Narva, A.S., N.R. Burrows, and S.D. Woodruff, Longer survival among native
Americans than among whites who initiated therapy for diabetes-related
end-stage renal disease, United States, 1990-2001. J Am Soc Nephrol, 2003.
14: p. 504A-504A.
12. Lightstone L. Preventing renal disease: the ethnic challenge in the United
Kingdom. Kidney Int. 2003;63(Supplement 83):S135–8.
13. van den Beukel TO, et al. Racial minority groups on dialysis in Europe: a
literature review. Clin Nephrol. 2010;74(SUPPL 1):S78–84.
14. Kalantar-Zadeh K, et al. Survival disparities within American and Israeli
dialysis populations: learning from similarities and distinctions across race
and ethnicity. Semin Dial. 2010;23(6):586–94.
15. Agodoa L, Eggers P. Racial and ethnic disparities in end-stage kidney
failure - survival paradoxes in African-Americans. Semin Dial. 2007;20(6):
577–85.
16. Leggat JE Jr, Swartz RD, Port FK. Withdrawal from dialysis: a review with an
emphasis on the black experience. Adv Ren Replace Ther. 1997;4(1):22–9.
17. Callender CO, et al. Blacks and whites and kidney transplantation: a disparity!
But why and why won't it go away? Transplant Rev. 2002;16(3):163–76.
18. Young CJ, Kew C. Health disparities in transplantation: focus on the
complexity and challenge of renal transplantation in African Americans.
Med Clin N Am. 2005;89(5):1003.
19. Garcia GG, Harden P, Chapman J. The global role of kidney transplantation.
Curr Opin Nephrol Hypertens. 2012;21(3):229–34.
20. Ghahramani N. Disparities in care of patients with end-stage renal disease:
Review of literature and action plan. Iran J Kidney Dis. 2007;1(2):47–53.
21. Vamos EP, Novak M, Mucsi I. Non-medical factors influencing access to renal
transplantation. Int Urol Nephrol. 2009;41(3):607–16.
22. Gaston RS, et al. Racial equity in renal-transplantation - the disparate impact
of HLA based allocation. Jama-Journal of the American Medical Association.
1993;270(11):1352–6.
23. Joshi S, Gaynor JJ, Ciancio G. Review of ethnic disparities in access to renal
transplantation. Clin Transpl. 2012;26(4):E337–43.
24. Wolfe W. Achieving equity in referrals for renal transplant evaluations with
afro-American patients: the role of nephrology social workers. Soc Work
Health Care. 2003;37(3):75–87.
25. Wolfe WA. Increasing African-American living kidney donors: the feasibility
and potential role of nephrology nurses and social workers. Soc Work
Health Care. 2003;37(4):73–89.
26. Malat GE, et al. African American kidney transplantation survival: the ability
of immunosuppression to balance the inherent pre- and post-transplant risk
factors. Drugs. 2009;69(15):2045–62.
27. Randhawa G. The impending kidney transplant crisis for the Asian
population in the UK. Public Health. 1998;112(4):265–8.
28. Stephens D. Exploring pathways to improve indigenous organ donation.
Intern Med J. 2007;37(10):713–6.
29. Barkercummings C, et al. Ethnic-differences in the use of peritoneal-dialysis
as INITIAL treatment for end-stage renal-disease. Jama-Journal of the
American Medical Association. 1995;274(23):1858–62.
30. Xue. Peritoneal and hemodialysis: I. Differences in patient characteristics at
initiation; 2002.
31. Mehrotra R, et al. Racial and ethnic disparities in use of and outcomes
with home Dialysis in the United States. J Am Soc Nephrol. 2016;27(7):
2123–34.
32. Khanal N, et al. Overview of dialysis in indigenous compared to
nonindigenous Australians. Clinical Nephrology. 2016;86(13):123–7.
33. McKercher C, et al. Gender differences in the dialysis treatment of
indigenous and non-indigenous Australians. Australian & New Zealand
Journal of Public Health. 2017;41(1):15–20.
34. Hemmelgarn BR, et al. Differences in use of peritoneal dialysis and survival
among east Asian, indo Asian, and white ESRD patients in Canada. Am J
Kidney Dis. 2006;48(6):964–71.
35. Teo BW, et al. Profile of hospitalisation and death in the first year after
diagnosis of end-stage renal disease in a multi-ethnic Asian population. Ann
Acad Med Singap. 2010;39(2):79–87.
36. Trehan A, et al. End-stage renal disease in indo-Asians in the north-West of
England. Qjm-an International Journal of Medicine. 2003;96(7):499–504.
37. RDS U. Incidence, prevalence, patient characteristics, & treatment modalities.
Am J Kidney Dis. 2014;63(1 SUPPL):e215–28.
38. Pruthi R, et al. UK renal registry 16th annual report: chapter 4 demography
of patients wait-listed for renal transplantation in the UK: national and
Centre-specific analyses. Nephron Clinical Practice. 2013;125(1–4):81–98.
39. Collins JF. Kidney disease in Maori and Pacific people in New Zealand. Clin
Nephrol. 2010;74:S61–5.
40. Cass A, et al. Renal transplantation for indigenous Australians: identifying
the barriers to equitable access. Ethnicity & Health. 2003;8(2):111–9.
41. Jeffrey RF, et al. Indo-Asian experience of renal transplantation in Yorkshire -
results of a 10-year survey. Transplantation. 2002;73(10):1652–7.
42. Pruthi R, et al. UK renal registry 15th annual report: chapter 9 Centre
variation in access to renal transplantation in the UK (2006-2008). Nephron -
Clinical Practice. 2013;123:183–93.
43. Garg PP, Diener-West M, Powe NR. Reducing racial disparities in transplant
activation: whom should we target? Am J Kidney Dis. 2001;37(5):921–31.
44. Purnell TS, et al. Racial differences in determinants of live donor kidney
transplantation in the United States. Am J Transplant. 2013;13(6):1557–65.
45. Mohandas R, et al. Racial and socioeconomic disparities in the allocation of
expanded criteria donor kidneys. Clinical Journal of The American Society of
Nephrology: CJASN. 2013;8(12):2158–64.
46. Gordon EJ. Patients' decisions for treatment of end-stage renal disease and
their implications for access to transplantation. Soc Sci Med. 2001;53(8):971–
87.
47. Wolfe RA, et al. Differences in access to cadaveric renal transplantation in
the United States. Am J Kidney Dis. 2000;36(5):1025–33.
48. Patibandla BK, et al. Disparities in arteriovenous fistula placement in older
hemodialysis patients. Hemodial Int. 2014;18(1):118–26.
49. Woo K, et al. Variations in outcomes of hemodialysis vascular access by
race/ethnicity in the elderly. J Vasc Surg. 2017;65(3):783–792.e4.
50. Zarkowsky DS, et al. Racial/ethnic disparities associated with Initial
hemodialysis access. JAMA Surgery. 2015;150(6):529–36.
51. Frankenfield DL, et al. Racial/ethnic analysis of selected intermediate
outcomes for hemodialysis patients: results from the 1997 ESRD core
indicators project. Am J Kidney Dis. 1999;34(4):721–30.
52. Frankenfield DL, et al. Survival advantage for adult Hispanic hemodialysis
patients? Findings from the end-stage renal disease clinical performance
measures project. J Am Soc Nephrol. 2003;14(1):180–6.
53. Rocco MV, et al. Intermediate outcomes by race and ethnicity in peritoneal
dialysis patients: results from the 1997 ESRD Core indicators project. Perit
Dial Int. 2000;20(3):328–35.
54. Marley JV, et al. Peritoneal dialysis outcomes of indigenous Australian
patients of remote Kimberley origin. Aust J Rural Health. 2014;22(3):
101–8.
55. Yan G, et al. Race/ethnicity, age, and risk of hospital admission and length
of stay during the first year of maintenance hemodialysis. Clinical Journal of
The American Society of Nephrology: CJASN. 2014;9(8):1402–9.
56. Beavers, Effect of Over-the-Counter Fish-Oil Administration on Plasma Lp(a)
Levels in an End-Stage Renal Disease Population. 2009.
57. Rock CL, et al. Racial group differences in plasma concentrations of
antioxidant vitamins and carotenoids in hemodialysis patients. Am J Clin
Nutr. 1997;65(3):844–50.
58. Bakewell A, Higgins R, Edmunds M. Nutrition, adequacy of dialysis, and
clinical outcome in indo-Asian and white European patients on peritoneal
dialysis. Qjm-an International Journal of Medicine. 2002;95(12):811–20.
59. Umeukeje EM, et al. Health care providers' support of patients' autonomy,
phosphate medication adherence, race and gender in end stage renal
disease. J Behav Med. 2016;39(6):1104–14.
60. Yang F, et al. Health-related quality of life of Asian patients with end-stage
renal disease (ESRD) in Singapore. Qual Life Res. 2015;24(9):2163–71.
Wilkinson et al. BMC Nephrology          (2019) 20:234 Page 10 of 12
61. Bakewell AB, Higgins RM, Edmunds ME. Quality of life in peritoneal dialysis
patients: decline over time and association with clinical outcomes. Kidney
Int. 2002;61(1):239–48.
62. Bakewell AB, Higgins RM, Edmunds ME. Does ethnicity influence perceived
quality of life of patients on dialysis and following renal transplant?
Nephrology Dialysis Transplantation. 2001;16(7):1395–401.
63. Greco P, Brickman AL, Routh DK. Depression and coping in candidates for
kidney transplantation: racial and ethnic differences. J Clin Psychol Med
Settings. 1996;3(4):337–53.
64. Akolekar D, Forsythe JLR, Oniscu GC. Impact of patient characteristics and
comorbidity profile on activation of patients on the kidney transplantation
waiting list. Transplant Proc. 2013;45(6):2115–22.
65. Keith D, et al. Insurance type and minority status associated with large
disparities in prelisting dialysis among candidates for kidney transplantation.
Clin J Am Soc Nephrol. 2008;3(2):463–70.
66. Sawinski, Factors associated with failure to list HIV-positive kidney transplant
candidates. 2009.
67. Lockwood MB, et al. Patient-reported barriers to the Prekidney transplant
evaluation in an at-risk population in the United States. Prog Transplant.
2017;27(2):131–8.
68. Monson RS, et al. Disparities in completion rates of the medical prerenal
transplant evaluation by race or ethnicity and gender. Transplantation. 2015;
99(1):236–42.
69. Alexander GC, Sehgal AR. Barriers to cadaveric renal transplantation among
blacks, women, and the poor. JAMA. 1998;280(13):1148–52.
70. Ismail SY, et al. Modifiable factors in access to living-donor kidney
transplantation among diverse populations. Transplantation. 2013;96(6):
586–90.
71. Browne T. The relationship between social networks and pathways to
kidney transplant parity: evidence from black Americans in Chicago. Soc Sci
Med. 2011;73(5):663–7.
72. Daw J. Of kin and kidneys: do kinship networks contribute to racial
disparities in living donor kidney transplantation? Soc Sci Med. 2014;
104:42–7.
73. Ismail SY, et al. Living donor kidney transplantation among ethnic minorities
in the Netherlands: a model for breaking the hurdles. Patient Educ Couns.
2013;90(1):118–24.
74. Ayanian JZ, et al. Physicians' beliefs about racial differences in referral for
renal transplantation. Am J Kidney Dis. 2004;43(2):350–7.
75. Cass. Decision-making about suitability for kidney transplantation - results of
a national survey of Australian nephrologists; 2007.
76. Reddan DN, et al. Racial inequity in America's ESRD program. Semin Dial.
2000;13(6):399–403.
77. Clark MD, et al. Prioritising patients for renal transplantation? Analysis of
patient preferences for kidney allocation according to ethnicity and gender.
Diversity in Health & Care. 2009;6(3):181–91.
78. Anderson K, et al. They really want to go back home, they hate it here: the
importance of place in Canadian health professionals' views on the barriers
facing aboriginal patients accessing kidney transplants. Health & Place. 2009;
15(1):390–3.
79. Daumit GL, et al. Use of cardiovascular procedures among black persons
and white persons: a 7-year nationwide study in patients with renal disease.
Ann Intern Med. 1999;130(3):173.
80. Pallet N, et al. Kidney transplant in black recipients: are African Europeans
different from African Americans ? Am J Transplant. 2005;5(11):2682–7.
81. Hall EC, et al. Center-level factors and racial disparities in living donor kidney
transplantation. Am J Kidney Dis. 2012;59(6):849–57.
82. Vranic GM, Ma JZ, Keith DS. The role of minority geographic distribution in
waiting time for deceased donor kidney transplantation. Am J Transplant.
2014;14(11):2526-34.
83. Gadalean F, et al. The survival of Roma minority patients on chronic
hemodialysis therapy - a Romanian multicenter survey. PLoS One. 2016;
11(5):e0155271.
84. Dyck RF, et al. End stage renal disease among people with diabetes: a
comparison of first nations people and other Saskatchewan residents from
1981 to 2005. Can J Diabetes. 2010;34(4):324–33.
85. Abidi SM, et al. Diabetic end-stage renal disease in the indigenous
population of the Commonwealth of the Northern Mariana Islands.
Nephrology. 2005;10(3):291–5.
86. Boan P, Swaminathan R, Irish A. Infectious complications in indigenous renal
transplant recipients in Western Australia. Intern Med J. 2017;47(6):648–55.
87. Chelluri LK, Vasantha A, Ratnakar KS. Impact of ethnicity, donor status and
HLA matching on renal allograft survival: a single center study. Saudi journal
of kidney diseases and transplantation : an official publication of the Saudi
Center for Organ Transplantation, Saudi Arabia. 2009;20(6):995–7.
88. Kucirka LM, et al. Association of race and age with survival among patients
undergoing dialysis. JAMA: Journal of the American Medical Association.
2011;306(6):620–6.
89. Arce CM, et al. Trends in relative mortality between Hispanic and non-
Hispanic whites initiating dialysis: a retrospective study of the US renal data
system. Am J Kidney Dis. 2013;62(2):312–21.
90. Pugh JA, Tuley MR, Basu S. Survival among MEXICAN-AMERICANS, non-
HISPANIC whites, and AFRICAN-AMERICANS with end-stage renal disease -
the emergence of a minority pattern of increased incidence and prolonged
survival. Am J Kidney Dis. 1994;23(6):803–7.
91. Murthy BVR, Molony DA, Stack AG. Survival advantage of Hispanic patients
initiating dialysis in the United States is modified by race. J Am Soc
Nephrol. 2005;16(3):782–90.
92. Medina RA, et al. Minority advantage in diabetic end-stage renal disease
survival on hemodialysis: due to different proportions of diabetic type? Am
J Kidney Dis. 1996;28(2):226–34.
93. Ríos Burrows N, et al. Survival on Dialysis among American Indians and
Alaska natives with diabetes in the United States, 1995-2010. Am J Public
Health. 2014;S3:S490–5.
94. Hall YN, et al. Differential mortality and transplantation rates among Asians
and Pacific islanders with ESRD. J Am Soc Nephrol. 2005;16(12):3711–20.
95. Fernandes NMD, et al. Association of Ethnicity and Survival in peritoneal
Dialysis: a cohort study of incident patients in Brazil. Am J Kidney Dis. 2013;
62(1):89–96.
96. Cole N, et al. Black ethnicity predicts better survival on dialysis despite
greater deprivation and co-morbidity: a UK study. Clin Nephrol. 2014;
82(2):77–82.
97. Frankenfield DL, et al. Differences in mortality among Mexican-American,
Puerto Rican, and Cuban-American dialysis patients in the United States.
Am J Kidney Dis. 2009;53(4):647–57.
98. Gomez-Puerta JA, et al. Racial and ethnic differences in mortality and
cardiovascular events among patients with end-stage renal disease due to
lupus nephritis. Arthritis Care & Research. 2015;67(10):1453–62.
99. Lopes AA, et al. Health-related quality of life and associated outcomes
among hemodialysis patients of different ethnicities in the United States:
the Dialysis outcomes and practice patterns study (DOPPS). Am J Kidney
Dis. 2003;41(3):605–15.
100. Mapes DL, et al. Health-related quality of life in the Dialysis outcomes and
practice patterns study (DOPPS). Am J Kidney Dis. 2004;44(SUPPL. 2):S54–60.
101. Hicks LS, et al. Differences in health-related quality of life and treatment
preferences among black and white patients with end-stage renal disease.
Qual Life Res. 2004;13(6):1129–37.
102. Jain P, et al. Survival and transplantation in end-stage renal disease: a
prospective study of a multiethnic population. Nephrology Dialysis
Transplantation. 2009;24(12):3840–6.
103. Tonelli M, et al. Patient and allograft survival of indo Asian and east Asian
dialysis patients treated in Canada. Kidney Int. 2007;72(4):499–504.
104. Harada. Risk Factors Associated with graft loss and patient survival after
kidney Transplantation; 2009.
105. El-Sabrout R, et al. African American and Caucasian renal transplant
recipients have equal acute rejection rates under sirolimus and tacrolimus
combination therapy. Graft. 2002;5(8):455–61.
106. Ilori TO, et al. Racial and ethnic disparities in graft and recipient survival in
elderly kidney transplant recipients. J Am Geriatr Soc. 2015;63(12):2485–93.
107. Karachristos A, et al. Outcomes of renal transplantation in older high risk
recipients: is there an age effect? J Surg Res. 2010;161(2):173–8.
108. Douzdijian V, et al. Effect of race on outcome after kidney and kidney-
pancreas transplantation in type 1 diabetic patients. Diabetes Care. 1997;
20(8):1310–4.
109. Young BA, et al. Racial and ethnic differences in incident myocardial infarction
in end-stage renal disease patients: the USRDS. Kidney Int. 2006;69(9):1691–8.
110. Abbott KC, et al. Hospitalized congestive heart failure after renal
transplantation in the United States. Ann Epidemiol. 2002;12(2):115–22.
111. Joshy G, et al. Ethnic differences in the natural progression of nephropathy
among diabetes patients in New Zealand: hospital admission rate for renal
complications, and incidence of end-stage renal disease and renal death.
Diabetologia. 2009;52(8):1474–8.
Wilkinson et al. BMC Nephrology          (2019) 20:234 Page 11 of 12
112. Leggat JE Jr, et al. An analysis of risk factors for withdrawal from dialysis
before death. J Am Soc Nephrol. 1997;8(11):1755–63.
113. Perry E, et al. Peer mentoring: a culturally sensitive approach to end-of-life
planning for long-term dialysis patients. Am J Kidney Dis. 2005;46(1):111–9.
114. Song M-K, et al. Racial differences in outcomes of an advance care planning
intervention for dialysis patients and their surrogates. J Palliat Med. 2016;
19(2):134–42.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Wilkinson et al. BMC Nephrology          (2019) 20:234 Page 12 of 12
